Market Place
Sourcing Support
Renovion Positive Ph2 CLIMB Results for ARINA-1 in Bronchiectasis
30 Apr 2024 //
BUSINESSWIRE
Renovion Completes Enrollment in Phase 2 CLIMB Study in Bronchiectasis
11 Jan 2024 //
BUSINESSWIRE
First Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1
18 Apr 2023 //
BUSINESSWIRE
Renovion enrols first subject in Phase II bronchiectasis therapy trial
03 Nov 2022 //
CLINICALTRIALSARENA
Renovion Announces First Patient Enrolled in Ph2 Study Evaluating ARINA-1
02 Nov 2022 //
BUSINESSWIRE
Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
02 Aug 2022 //
BUSINESSWIRE
Renovion Provides Regulatory Update and Initiation of Clinical Program
26 Apr 2022 //
BUSINESSWIRE
Marty Zamora, MD Joins Renovion, Inc. as Chief Medical Officer
12 Apr 2022 //
BUSINESSWIRE
Renovion & COPD Foundation Partner to Address Unmet Patient Need in lung issues
21 Sep 2021 //
BUSINESSWIRE
Renovion Announces Addition of Rich Mattingly to Board of Directors
26 Aug 2020 //
BUSINESSWIRE
Renovion Announces Publication of Research Demonstrating the Impact of the Novel
08 Jul 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.